Authum Investment & Infrastructure Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 12:32 am

Competitors of Authum Investment & Infrastructure Ltd

All Competitor Stocks of Authum Investment & Infrastructure Ltd

Quarterly Result

Last Updated: July 16, 2025, 12:58 pm

Below is a detailed analysis of the quarterly data for Authum Investment & Infrastructure Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,215.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,452.00 Cr. (Mar 2025) to 1,215.00 Cr., marking a decrease of 237.00 Cr..
• For Expenses, as of Jun 2025, the value is 56.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 188.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 132.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 1,159.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,264.00 Cr. (Mar 2025) to 1,159.00 Cr., marking a decrease of 105.00 Cr..
• For OPM %, as of Jun 2025, the value is 95.00%. The value appears strong and on an upward trend. It has increased from 87.00% (Mar 2025) to 95.00%, marking an increase of 8.00%.
• For Other Income, as of Jun 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 4.00 Cr..
• For Interest, as of Jun 2025, the value is 21.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.00 Cr. (Mar 2025) to 21.00 Cr., marking an increase of 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 1,144.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,248.00 Cr. (Mar 2025) to 1,144.00 Cr., marking a decrease of 104.00 Cr..
• For Tax %, as of Jun 2025, the value is 18.00%. The value appears to be increasing, which may not be favorable. It has increased from -41.00% (Mar 2025) to 18.00%, marking an increase of 59.00%.
• For Net Profit, as of Jun 2025, the value is 943.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,763.00 Cr. (Mar 2025) to 943.00 Cr., marking a decrease of 820.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 55.52. The value appears to be declining and may need further review. It has decreased from 103.78 (Mar 2025) to 55.52, marking a decrease of 48.26.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:29 pm

Growth

Last Updated: September 5, 2025, 2:31 pm

Balance Sheet

Last Updated: October 10, 2025, 3:33 pm

Below is a detailed analysis of the balance sheet data for Authum Investment & Infrastructure Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 17.00 Cr..
• For Reserves, as of Mar 2025, the value is 14,672.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,328.00 Cr. (Mar 2024) to 14,672.00 Cr., marking an increase of 4,344.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,054.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,128.00 Cr. (Mar 2024) to 1,054.00 Cr., marking a decrease of 74.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 344.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 148.00 Cr. (Mar 2024) to 344.00 Cr., marking an increase of 196.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 16,087.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11,621.00 Cr. (Mar 2024) to 16,087.00 Cr., marking an increase of 4,466.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 414.00 Cr.. The value appears strong and on an upward trend. It has increased from 355.00 Cr. (Mar 2024) to 414.00 Cr., marking an increase of 59.00 Cr..
• For CWIP, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 6.00 Cr., marking an increase of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 12,739.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,940.00 Cr. (Mar 2024) to 12,739.00 Cr., marking an increase of 3,799.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,928.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,324.00 Cr. (Mar 2024) to 2,928.00 Cr., marking an increase of 604.00 Cr..
• For Total Assets, as of Mar 2025, the value is 16,087.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,621.00 Cr. (Mar 2024) to 16,087.00 Cr., marking an increase of 4,466.00 Cr..

Notably, the Reserves (14,672.00 Cr.) exceed the Borrowings (1,054.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Authum Investment & Infrastructure Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 249.72. This value is within the healthy range. It has decreased from 252.28 (Mar 24) to 249.72, marking a decrease of 2.56.
• For Diluted EPS (Rs.), as of Mar 25, the value is 249.72. This value is within the healthy range. It has decreased from 252.28 (Mar 24) to 249.72, marking a decrease of 2.56.
• For Cash EPS (Rs.), as of Mar 25, the value is 250.35. This value is within the healthy range. It has decreased from 252.83 (Mar 24) to 250.35, marking a decrease of 2.48.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 865.10. It has increased from 609.25 (Mar 24) to 865.10, marking an increase of 255.85.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 865.10. It has increased from 609.25 (Mar 24) to 865.10, marking an increase of 255.85.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 269.63. It has increased from 152.34 (Mar 24) to 269.63, marking an increase of 117.29.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 243.15. This value is within the healthy range. It has decreased from 249.79 (Mar 24) to 243.15, marking a decrease of 6.64.
• For PBIT / Share (Rs.), as of Mar 25, the value is 242.59. This value is within the healthy range. It has decreased from 249.30 (Mar 24) to 242.59, marking a decrease of 6.71.
• For PBT / Share (Rs.), as of Mar 25, the value is 239.53. This value is within the healthy range. It has decreased from 248.86 (Mar 24) to 239.53, marking a decrease of 9.33.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 249.79. This value is within the healthy range. It has decreased from 252.35 (Mar 24) to 249.79, marking a decrease of 2.56.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 249.79. This value is within the healthy range. It has decreased from 252.35 (Mar 24) to 249.79, marking a decrease of 2.56.
• For PBDIT Margin (%), as of Mar 25, the value is 90.17. This value is within the healthy range. It has decreased from 163.96 (Mar 24) to 90.17, marking a decrease of 73.79.
• For PBIT Margin (%), as of Mar 25, the value is 89.97. This value exceeds the healthy maximum of 20. It has decreased from 163.64 (Mar 24) to 89.97, marking a decrease of 73.67.
• For PBT Margin (%), as of Mar 25, the value is 88.83. This value is within the healthy range. It has decreased from 163.35 (Mar 24) to 88.83, marking a decrease of 74.52.
• For Net Profit Margin (%), as of Mar 25, the value is 92.64. This value exceeds the healthy maximum of 10. It has decreased from 165.64 (Mar 24) to 92.64, marking a decrease of 73.00.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 92.64. This value exceeds the healthy maximum of 20. It has decreased from 165.64 (Mar 24) to 92.64, marking a decrease of 73.00.
• For Return on Networth / Equity (%), as of Mar 25, the value is 28.87. This value is within the healthy range. It has decreased from 41.41 (Mar 24) to 28.87, marking a decrease of 12.54.
• For Return on Capital Employeed (%), as of Mar 25, the value is 27.66. This value is within the healthy range. It has decreased from 40.58 (Mar 24) to 27.66, marking a decrease of 12.92.
• For Return On Assets (%), as of Mar 25, the value is 26.36. This value is within the healthy range. It has decreased from 36.87 (Mar 24) to 26.36, marking a decrease of 10.51.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.04. This value is within the healthy range. It has decreased from 0.06 (Mar 24) to 0.04, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has increased from 0.27 (Mar 24) to 0.33, marking an increase of 0.06.
• For Current Ratio (X), as of Mar 25, the value is 12.89. This value exceeds the healthy maximum of 3. It has increased from 9.31 (Mar 24) to 12.89, marking an increase of 3.58.
• For Quick Ratio (X), as of Mar 25, the value is 12.89. This value exceeds the healthy maximum of 2. It has increased from 9.31 (Mar 24) to 12.89, marking an increase of 3.58.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 79.41. This value is within the healthy range. It has increased from 65.03 (Mar 24) to 79.41, marking an increase of 14.38.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 82.58. This value is within the healthy range. It has increased from 65.81 (Mar 24) to 82.58, marking an increase of 16.77.
• For Enterprise Value (Cr.), as of Mar 25, the value is 29,702.47. It has increased from 12,497.52 (Mar 24) to 29,702.47, marking an increase of 17,204.95.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.49. This value exceeds the healthy maximum of 3. It has increased from 4.83 (Mar 24) to 6.49, marking an increase of 1.66.
• For EV / EBITDA (X), as of Mar 25, the value is 7.19. This value is within the healthy range. It has increased from 2.95 (Mar 24) to 7.19, marking an increase of 4.24.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.42. This value exceeds the healthy maximum of 3. It has increased from 4.76 (Mar 24) to 6.42, marking an increase of 1.66.
• For Price / BV (X), as of Mar 25, the value is 2.00. This value is within the healthy range. It has increased from 1.19 (Mar 24) to 2.00, marking an increase of 0.81.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.42. This value exceeds the healthy maximum of 3. It has increased from 4.76 (Mar 24) to 6.42, marking an increase of 1.66.
• For EarningsYield, as of Mar 25, the value is 0.14. This value is below the healthy minimum of 5. It has decreased from 0.34 (Mar 24) to 0.14, marking a decrease of 0.20.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness